ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 102 filers reported holding ENDOCYTE INC in Q2 2014. The put-call ratio across all filers is 4.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $387,417 | -99.9% | 21,814 | 0.0% | 0.01% | +40.0% |
| Q2 2018 | $301,034,000 | +224552.2% | 21,814 | -25.7% | 0.01% | +400.0% |
| Q3 2015 | $134,000 | -36.2% | 29,340 | -12.4% | 0.00% | -50.0% |
| Q1 2015 | $210,000 | 0.0% | 33,505 | +0.5% | 0.00% | +100.0% |
| Q4 2014 | $210,000 | +3.4% | 33,337 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $203,000 | -7.7% | 33,337 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $220,000 | -64.7% | 33,337 | +27.2% | 0.00% | -50.0% |
| Q1 2014 | $624,000 | +122.9% | 26,208 | 0.0% | 0.00% | +100.0% |
| Q4 2013 | $280,000 | -19.8% | 26,208 | 0.0% | 0.00% | -33.3% |
| Q3 2013 | $349,000 | +1.5% | 26,208 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $344,000 | – | 26,208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,211,302 | $74,793,000 | 19.97% |
| VHCP Management III, LLC | 600,000 | $10,656,000 | 8.05% |
| RA Capital Management | 6,196,143 | $110,043,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 1,606,100 | $28,524,000 | 4.44% |
| Avoro Capital Advisors LLC | 5,301,718 | $94,159,000 | 4.32% |
| Ghost Tree Capital, LLC | 1,100,000 | $19,536,000 | 4.15% |
| Crosspoint Capital Strategies, LLC | 104,573 | $1,857,000 | 3.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,514,084 | $62,410,000 | 2.24% |
| NEXTHERA CAPITAL LP | 654,532 | $11,624,000 | 2.23% |
| EMORY UNIVERSITY | 148,628 | $2,640,000 | 1.73% |